Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Gene Therapeutics & RNAi

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2057470

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2057470

Protein Expression Market by Product (Instruments, Reagents, Kits, Consumables, Software, Services), System Type (Mammalian, Insect, Yeast), Workflow (Cloning, Translation, PTM), Scale, Protein Type, Application, Competition - Global Forecast to 2031

PUBLISHED:
PAGES: 749 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global protein expression market is estimated to reach USD 7.65 billion by 2031, up from USD 5.14 billion in 2026, at a CAGR of 8.3% from 2026 to 2031. The global protein expression market is projected to witness strong growth over the forecast period, driven by the expanding biologics and biosimilars pipeline, increasing demand for recombinant proteins, and growth in advanced modalities such as cell and gene therapies and mRNA products.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsOffering, type, workflow, scale of operation, protein modality, application, product end user, service end user
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa

Market estimates indicate robust expansion through 2031, supported by technological advancements in expression systems and rising biologics manufacturing activities. However, high costs of advanced expression technologies, process scalability challenges, the need for specialized expertise, and varying regulatory requirements across regions are expected to restrain broader market growth.

Protein Expression Market - IMG1

"The product segment accounted for the largest share, by offering, in 2025."

Based on offerings, the protein expression market is broadly segmented into products and services. In 2025, products accounted for the largest share of the protein expression market, driven by their extensive use in routine protein production workflows, including cell culture, transfection, vector preparation, protein purification, and expression optimization. Their ease of use, recurring purchase requirements, and compatibility with automated and high-throughput platforms make them essential across research and manufacturing environments. Additionally, their cost-effectiveness and ability to enable reproducible, efficient protein production continue to drive strong demand from biopharmaceutical companies, CROs, academic institutions, and research laboratories globally.

"Mammalian expression systems accounted for the largest share of the protein expression market, by type, in 2025."

Based on type, the global protein expression market is segmented into mammalian, prokaryotic, insect, yeast, cell-free, and algal & plant-based expression systems. The mammalian expression systems segment accounted for the largest share of the protein expression market in 2025, due to its widespread use in producing complex recombinant proteins, monoclonal antibodies, and therapeutic biologics. These systems enable proper protein folding, post-translational modifications, and glycosylation patterns essential for biopharmaceutical applications. Additionally, the expanding biologics pipeline, increasing demand for high-quality therapeutic proteins, and growing commercial-scale manufacturing activities continue to strengthen the segment's leading market position globally.

"The Asia Pacific is growing at the highest CAGR in the protein expression market from 2026 to 2031."

The protein expression market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. During the forecast period, the Asia Pacific region is estimated to grow at the highest CAGR, driven by expanding biopharmaceutical manufacturing, rising investments in biotechnology research, and increasing demand for biologics and biosimilars. Growth is further driven by the rapid expansion of contract research and manufacturing organizations (CROs/CDMOs), improvements in healthcare and research infrastructure, and the increasing adoption of advanced protein expression technologies. Additionally, the presence of major regional and global players, including Samsung Biologics and WuXi AppTec, continues to strengthen biologics development and protein production capabilities across the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side - 70% and Demand Side - 30%
  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: CXOs and Directors - 30%, Managers - 45%, and Others - 25%
  • By Region: North America - 40%, Europe - 25%, Asia Pacific - 20%, Latin America - 10%, and the Middle East - 5%

List of Companies Profiled in the Report

  • Thermo Fisher Scientific Inc.
  • Merck Kgaa
  • Danaher Corporation
  • Agilent Technologies, Inc
  • Sartorius Ag
  • Genscript
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc
  • QIAGEN
  • Charles River Laboratories
  • Corning Incorporated
  • Lonza
  • Fujifilm Corporation
  • Syngene International
  • Lgc Limited
  • Eurofins Scientific
  • Ajinomoto Co., Inc

Research Coverage

This research report categorizes the protein expression market by offering, type, workflow, scale of operation, protein modality, application, by end user (product & service end users), and by region. The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints, influencing the growth of the protein expression market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product portfolio, key strategies such as product and service approvals and launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the protein expression market. This report covers competitive analysis of top players and upcoming startups in the protein expression market ecosystem.

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing the closest approximations of revenue for the overall protein expression market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business more effectively and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (increasing global biologics and biosimilar pipeline, rising government and venture capital R&D funding, continuous innovation in expression technologies), restraints (high capital and operational costs), opportunities (emerging algal expression systems and broader adoption of platforms such as cell-free, plant-based expression systems, AI/ML-driven expression optimization) and challenges (scalability Challenge from bench to GMP manufacturing) influencing the growth of protein expression market
  • Product Development/Innovation: Detailed insights on newly launched products of the protein expression market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the protein expression market across varied regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the protein expression market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Agilent Technologies, Inc. (US), Sartorius AG (Germany), among others
Show more
Product Code: BT 2757

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 PROTEIN EXPRESSION MARKET OVERVIEW
  • 3.2 PROTEIN EXPRESSION MARKET, BY OFFERING & REGION
  • 3.3 PROTEIN EXPRESSION MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Increasing global biologics and biosimilars pipeline
      • 4.2.1.2 Rising government and venture capital R&D funding
      • 4.2.1.3 Continuous innovation in expression technologies
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High capital and operational costs
    • 4.2.3 OPPORTUNITY
      • 4.2.3.1 Emerging algal expression systems and rising adoption of advanced platforms
      • 4.2.3.2 Al/ML-driven expression optimization
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Scalability challenges from bench to GMP manufacturing
  • 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 BARGAINING POWER OF SUPPLIERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL PROTEIN EXPRESSION MARKET
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 PROTEIN EXPRESSION PRODUCTS
    • 5.3.2 PROTEIN EXPRESSION SERVICES
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
    • 5.5.2 INDICATIVE SELLING PRICE, BY REGION, 2025
  • 5.6 TRADE ANALYSIS
    • 5.6.1 IMPORT SCENARIO FOR HS CODE 902781
    • 5.6.2 EXPORT SCENARIO FOR HS CODE 902781
  • 5.7 KEY CONFERENCES & EVENTS
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 INVESTMENT/FUNDING SCENARIO
  • 5.10 IMPACT OF US TARIFFS-PROTEIN EXPRESSION MARKET
    • 5.10.1 INTRODUCTION
    • 5.10.2 KEY TARIFF RATES
    • 5.10.3 PRICE IMPACT ANALYSIS
    • 5.10.4 IMPACT ON COUNTRIES/REGIONS
      • 5.10.4.1 North America
      • 5.10.4.2 Europe
      • 5.10.4.3 Asia Pacific
    • 5.10.5 IMPACT ON END-USE INDUSTRIES
      • 5.10.5.1 Pharmaceutical and biotechnology companies
      • 5.10.5.2 Academic & Research Institutes
      • 5.10.5.3 CROs & CDMOs
  • 5.11 BIOMANUFACTURING CAPACITY
  • 5.12 NIH FUNDING FOR PROTEIN-RELATED RESEARCH

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY TECHNOLOGIES
    • 6.1.1 RECOMBINANT DNA TECHNOLOGY
    • 6.1.2 TRANSFECTION TECHNOLOGIES
  • 6.2 ADJACENT TECHNOLOGIES
    • 6.2.1 EXTRACTION TECHNOLOGIES
  • 6.3 COMPLEMENTARY TECHNOLOGIES
    • 6.3.1 HIGH-THROUGHPUT TECHNOLOGIES
    • 6.3.2 COMPUTATION PROTEIN DESIGNING
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.5 PATENT ANALYSIS
    • 6.5.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR PROTEIN EXPRESSION PATENTS, 2015-2025
  • 6.6 FUTURE APPLICATIONS
  • 6.7 IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET
    • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.7.2 CASE STUDIES OF AI IMPLEMENTATION IN PROTEIN EXPRESSION MARKET
    • 6.7.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.7.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PROTEIN EXPRESSION MARKET

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 REGULATORY FRAMEWORK
    • 7.1.3 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
  • 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 KEY BUYING CRITERIA, BY END USER
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY

9 PROTEIN EXPRESSION MARKET, BY OFFERING

  • 9.1 INTRODUCTION
  • 9.2 PRODUCTS
    • 9.2.1 REAGENTS
      • 9.2.1.1 Culture media & supplements
        • 9.2.1.1.1 Optimized and GMP-ready media formulations to support scalable protein expression
      • 9.2.1.2 Expression vectors & plasmids
        • 9.2.1.2.1 Growing production of complex proteins to propel market
      • 9.2.1.3 Transduction & transfection reagents
        • 9.2.1.3.1 High-efficiency gene delivery reagents to improve transient and stable protein expression
      • 9.2.1.4 Competent cells
        • 9.2.1.4.1 Increasing demand for therapeutic proteins to expedite growth
      • 9.2.1.5 Other reagents
    • 9.2.2 INSTRUMENTS
      • 9.2.2.1 Bioreactors & fermenters
        • 9.2.2.1.1 Rising biologics research to drive adoption of advanced bioreactor systems
      • 9.2.2.2 Chromatography systems
        • 9.2.2.2.1 Expanding recombinant protein and antibody research accelerates demand for automated lab-scale systems
      • 9.2.2.3 Analytical instruments
        • 9.2.2.3.1 Rising need for rapid protein quality assessment and characterization drives demand for analytical instruments
      • 9.2.2.4 Liquid handling & automated systems
        • 9.2.2.4.1 High-throughput expression screening and workflow miniaturization to propel adoption
      • 9.2.2.5 Filtration systems
        • 9.2.2.5.1 Growing need for rapid and scalable post-expression processing driving global adoption
      • 9.2.2.6 Other instruments
    • 9.2.3 CONSUMABLES
      • 9.2.3.1 Chromatography & purification consumables
        • 9.2.3.1.1 Increasing need for high-purity recombinant proteins is accelerating adoption
      • 9.2.3.2 Filtration & separation consumables
        • 9.2.3.2.1 Rising demand for rapid, small-scale protein processing workflows is driving growth
      • 9.2.3.3 Other consumables
    • 9.2.4 KITS
      • 9.2.4.1 Expression kits
        • 9.2.4.1.1 Standardized, high-throughput expression kits accelerate recombinant protein discovery and workflow reproducibility
      • 9.2.4.2 Cloning & mutagenesis kits
        • 9.2.4.2.1 Rapid construct engineering kits to accelerate expression-ready clone development
      • 9.2.4.3 Other kits
    • 9.2.5 SOFTWARE
      • 9.2.5.1 AI-enabled design, codon optimization, and workflow informatics drive software adoption
  • 9.3 SERVICES
    • 9.3.1 CUSTOM PROTEIN EXPRESSION SERVICES
      • 9.3.1.1 Rising demand for specialized recombinant protein production supports expansion of custom services
    • 9.3.2 GENE SYNTHESIS & CLONING SERVICES
      • 9.3.2.1 Reduced workload, improved accuracy, optimized workflows to drive demand
    • 9.3.3 CELL LINE DEVELOPMENT (CLD) SERVICES
      • 9.3.3.1 Outsourcing of high-yield mammalian cell line development drives growth
    • 9.3.4 PROCESS DEVELOPMENT & SCALE-UP SERVICES
      • 9.3.4.1 Rising need to translate expression hits into scalable preclinical protein production supports demand growth

10 PROTEIN EXPRESSION MARKET, BY TYPE

  • 10.1 INTRODUCTION
  • 10.2 MAMMALIAN CELL EXPRESSION SYSTEMS
    • 10.2.1 CHINESE HAMSTER OVARY (CHO) CELL SYSTEMS
      • 10.2.1.1 High viability, rapid growth, and improved expression levels to support growth
    • 10.2.2 HUMAN EMBRYONIC KIDNEY (HEK 293) CELL SYSTEMS
      • 10.2.2.1 Wide usage in transient transfection studies to augment growth
    • 10.2.3 OTHER MAMMALIAN CELL EXPRESSION SYSTEMS
  • 10.3 PROKARYOTIC EXPRESSION SYSTEMS
    • 10.3.1 ESCHERICHIA COLI SYSTEMS
      • 10.3.1.1 Increasing use of E. coli systems for commercial protein production to support market
    • 10.3.2 BACILLUS SYSTEMS
      • 10.3.2.1 Efficient secretion capabilities drive growing adoption
    • 10.3.3 OTHER PROKARYOTIC EXPRESSION SYSTEMS
  • 10.4 INSECT CELL EXPRESSION SYSTEMS
    • 10.4.1 BACULOVIRUS SYSTEMS
      • 10.4.1.1 High protein yield and expression levels of intracellular proteins through the baculovirus expression system to support growth
    • 10.4.2 OTHER INSECT CELL SYSTEMS
  • 10.5 YEAST EXPRESSION SYSTEMS
    • 10.5.1 PICHIA SYSTEMS
      • 10.5.1.1 High scalability and efficient protein production to support growth
    • 10.5.2 SACCHAROMYCES SYSTEMS
      • 10.5.2.1 Efficient secretory pathways and scalable recombinant protein production to support market growth
    • 10.5.3 OTHER YEAST EXPRESSION SYSTEMS
  • 10.6 CELL-FREE EXPRESSION SYSTEMS
    • 10.6.1 E. COLI LYSATE-BASED SYSTEMS
      • 10.6.1.1 Rapid and flexible platforms for protein synthesis to drive adoption
    • 10.6.2 OTHER CELL-FREE EXPRESSION SYSTEMS
  • 10.7 ALGAL & PLANT-BASED EXPRESSION SYSTEMS
    • 10.7.1 GROWTH IN VACCINES MARKET TO SUPPORT SEGMENT

11 PROTEIN EXPRESSION MARKET, BY WORKFLOW

  • 11.1 INTRODUCTION
  • 11.2 CLONING & TRANSFECTION
    • 11.2.1 CONTINUOUS REPLENISHMENT OF CONSUMABLES AND REAGENTS TO SUPPORT THE MARKET
  • 11.3 TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION (PTM)
    • 11.3.1 GROWING NEED FOR FUNCTIONAL AND STABLE PROTEINS TO DRIVE MARKET
  • 11.4 EXTRACTION, PURIFICATION, AND CHARACTERIZATION
    • 11.4.1 NEED TO ADHERE TO REQUIRED STANDARDS FOR SUITABLE APPLICATIONS TO DRIVE MARKET

12 PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION

  • 12.1 INTRODUCTION
  • 12.2 DISCOVERY & RESEARCH SCALE
    • 12.2.1 EXPANDING BIOLOGICS PIPELINE AND FOCUS ON COMPUTATIONALLY DESIGNED PROTEINS TO AID GROWTH
  • 12.3 PRECLINICAL & CHARACTERIZATION SCALE
    • 12.3.1 SIGNIFICANT NUMBER OF BIOLOGIC CANDIDATES ENTERING PRE-CLINICAL DEVELOPMENT TO BOOST THE MARKET
  • 12.4 PROCESS DEVELOPMENT & PILOT SCALE
    • 12.4.1 INCREASING OUTSOURCING OF EXPRESSION AT PROCESS DEVELOPMENT SCALE TO SUPPORT GROWTH

13 PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY

  • 13.1 INTRODUCTION
  • 13.2 MONOCLONAL ANTIBODIES & DERIVATIVES
    • 13.2.1 EXPANDING ANTIBODY DISCOVERY, BISPECIFIC DEVELOPMENT, AND MAMMALIAN EXPRESSION OPTIMIZATION DRIVE DEMAND
  • 13.3 RECOMBINANT THERAPEUTIC PROTEINS
    • 13.3.1 INCREASING DEVELOPMENT OF RECOMBINANT BIOLOGICS AND ENGINEERED THERAPEUTIC PROTEINS IS DRIVING DEMAND
  • 13.4 VACCINES
    • 13.4.1 RISING DEMAND FOR RECOMBINANT ANTIGENS AND NEXT-GENERATION VACCINE PLATFORMS DRIVES PROTEIN EXPRESSION ADOPTION IN VACCINE RESEARCH
  • 13.5 ENZYMES & CATALYTIC PROTEINS
    • 13.5.1 EXPANDING ENZYME ENGINEERING AND BIOCATALYSIS APPLICATIONS ARE ACCELERATING DEMAND
  • 13.6 OTHER PROTEINS

14 PROTEIN EXPRESSION MARKET, BY APPLICATION

  • 14.1 INTRODUCTION
  • 14.2 THERAPEUTIC APPLICATIONS
    • 14.2.1 RISING DEMAND FOR BIOLOGICS THERAPIES TO FACILITATE GROWTH
  • 14.3 RESEARCH APPLICATIONS
    • 14.3.1 GROWING INTEREST IN PROTEOMICS, GENOMICS, AND DRUG DISCOVERY TO BOOST MARKET
  • 14.4 INDUSTRIAL APPLICATIONS
    • 14.4.1 INCREASING USE OF PROTEINS IN COSMETICS, TEXTILES, AND INDUSTRIAL ENZYMES TO PROMOTE GROWTH
  • 14.5 DIAGNOSTIC APPLICATIONS
    • 14.5.1 RECOMBINANT PROTEINS AND ASSAY-READY REAGENTS TO STRENGTHEN DIAGNOSTIC DEVELOPMENT

15 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER

  • 15.1 INTRODUCTION
  • 15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 15.2.1 RISING INVESTMENT IN BIOLOGICS AND INCREASING APPROVALS FOR BIOLOGICS TO SUPPORT GROWTH
  • 15.3 CROS & CDMOS
    • 15.3.1 INCREASE IN OUTSOURCING AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING TO BOOST MARKET
  • 15.4 ACADEMIC & RESEARCH INSTITUTES
    • 15.4.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET
  • 15.5 OTHER END USERS

16 PROTEIN EXPRESSION SERVICES MARKET, BY END USER

  • 16.1 INTRODUCTION
  • 16.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 16.2.1 INCREASING SHIFT TOWARD DRUG DEVELOPMENT OUTSOURCING TO FAVOR GROWTH
  • 16.3 ACADEMIC & RESEARCH INSTITUTES
    • 16.3.1 RISING PARTNERSHIPS BETWEEN ACADEMIA AND CONTRACT RESEARCH ORGANIZATIONS TO AID GROWTH
  • 16.4 OTHER END USERS

17 PROTEIN EXPRESSION MARKET, BY REGION

  • 17.1 INTRODUCTION
  • 17.2 NORTH AMERICA
    • 17.2.1 US
      • 17.2.1.1 Growing focus on developing new therapeutics and protein-based drugs to drive market
    • 17.2.2 CANADA
      • 17.2.2.1 Increasing incidence of cancer and prevalence of public-private partnerships to sustain growth
  • 17.3 EUROPE
    • 17.3.1 GERMANY
      • 17.3.1.1 Increasing proteomics-based research and healthcare investments to promote growth
    • 17.3.2 UK
      • 17.3.2.1 Growing development of immunotherapies, vaccines, and proteomics to fuel market
    • 17.3.3 FRANCE
      • 17.3.3.1 Rise in funding for proteomics and genomics to spur growth
    • 17.3.4 ITALY
      • 17.3.4.1 Growing life science research supported by universities and research institutions to boost market
    • 17.3.5 SPAIN
      • 17.3.5.1 Growing expansion of biotech companies and increasing R&D expenditure to drive market
    • 17.3.6 NETHERLANDS
      • 17.3.6.1 Presence of advanced infrastructure to fuel market
    • 17.3.7 REST OF EUROPE
  • 17.4 ASIA PACIFIC
    • 17.4.1 CHINA
      • 17.4.1.1 Rising biologics development driving market growth
    • 17.4.2 JAPAN
      • 17.4.2.1 Growing government initiatives and expansion of biopharma companies to boost market
    • 17.4.3 INDIA
      • 17.4.3.1 Rising collaborations between private sector and academia to facilitate growth
    • 17.4.4 AUSTRALIA
      • 17.4.4.1 Strong regulatory framework, clinical innovation, and global partnerships drive market growth
    • 17.4.5 SOUTH KOREA
      • 17.4.5.1 Increasing research & development of novel therapies to facilitate growth
    • 17.4.6 REST OF ASIA PACIFIC
  • 17.5 LATIN AMERICA
    • 17.5.1 BRAZIL
      • 17.5.1.1 Growing industrial investments to propel market
    • 17.5.2 MEXICO
      • 17.5.2.1 Increasing government support for biopharmaceutical production to drive market
    • 17.5.3 ARGENTINA
      • 17.5.3.1 Rise in biotechnology and pharmaceutical research & development to augment growth
    • 17.5.4 REST OF LATIN AMERICA
  • 17.6 MIDDLE EAST
    • 17.6.1 GCC COUNTRIES
      • 17.6.1.1 Saudi Arabia
        • 17.6.1.1.1 Rising demand for biologics and increasing healthcare investments to support market growth
      • 17.6.1.2 United Arab Emirates
        • 17.6.1.2.1 Developing biopharma sector to drive market
      • 17.6.1.3 Rest of GCC countries
    • 17.6.2 REST OF MIDDLE EAST
  • 17.7 AFRICA

18 COMPETITIVE LANDSCAPE

  • 18.1 OVERVIEW
  • 18.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 18.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PROTEIN EXPRESSION MARKET
  • 18.3 REVENUE ANALYSIS
  • 18.4 MARKET SHARE ANALYSIS
  • 18.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 18.5.1 STARS
    • 18.5.2 EMERGING LEADERS
    • 18.5.3 PERVASIVE PLAYERS
    • 18.5.4 PARTICIPANTS
    • 18.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 18.5.5.1 Company footprint
      • 18.5.5.2 Region footprint
      • 18.5.5.3 Offering footprint
      • 18.5.5.4 Type footprint
      • 18.5.5.5 Application footprint
  • 18.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 18.6.1 PROGRESSIVE COMPANIES
    • 18.6.2 RESPONSIVE COMPANIES
    • 18.6.3 DYNAMIC COMPANIES
    • 18.6.4 STARTING BLOCKS
    • 18.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 18.6.5.1 Detailed list of key startups/SMEs
      • 18.6.5.2 Competitive benchmarking of key startups/SMEs
  • 18.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 18.7.1 COMPANY VALUATION
    • 18.7.2 FINANCIAL METRICS
  • 18.8 BRAND/PRODUCT COMPARISON
  • 18.9 COMPETITIVE SCENARIO
    • 18.9.1 PRODUCT & SERVICE LAUNCHES
    • 18.9.2 DEALS
    • 18.9.3 EXPANSIONS

19 COMPANY PROFILES

  • 19.1 MAJOR PLAYERS
    • 19.1.1 THERMO FISHER SCIENTIFIC INC.
      • 19.1.1.1 Business overview
      • 19.1.1.2 Products & services offered
      • 19.1.1.3 Recent developments
        • 19.1.1.3.1 Product & service launches
        • 19.1.1.3.2 Deals
        • 19.1.1.3.3 Expansions
      • 19.1.1.4 MnM view
        • 19.1.1.4.1 Key strengths
        • 19.1.1.4.2 Strategic choices
        • 19.1.1.4.3 Weaknesses and competitive threats
    • 19.1.2 MERCK KGAA
      • 19.1.2.1 Business overview
      • 19.1.2.2 Products & services offered
      • 19.1.2.3 Recent developments
        • 19.1.2.3.1 Deals
        • 19.1.2.3.2 Expansions
      • 19.1.2.4 MnM view
        • 19.1.2.4.1 Key strengths
        • 19.1.2.4.2 Strategic choices
        • 19.1.2.4.3 Weaknesses and competitive threats
    • 19.1.3 DANAHER CORPORATION
      • 19.1.3.1 Business overview
      • 19.1.3.2 Products & services offered
      • 19.1.3.3 Recent developments
        • 19.1.3.3.1 Product launches
        • 19.1.3.3.2 Deals
        • 19.1.3.3.3 Expansions
      • 19.1.3.4 MnM view
        • 19.1.3.4.1 Key strengths
        • 19.1.3.4.2 Strategic choices
        • 19.1.3.4.3 Weaknesses and competitive threats
    • 19.1.4 AGILENT TECHNOLOGIES, INC.
      • 19.1.4.1 Business overview
      • 19.1.4.2 Products & services offered
      • 19.1.4.3 Recent developments
        • 19.1.4.3.1 Product launches
        • 19.1.4.3.2 Deals
      • 19.1.4.4 MnM view
        • 19.1.4.4.1 Key strengths
        • 19.1.4.4.2 Strategic choices
        • 19.1.4.4.3 Weaknesses and competitive threats
    • 19.1.5 SARTORIUS AG
      • 19.1.5.1 Business overview
      • 19.1.5.2 Products & services offered
      • 19.1.5.3 Recent developments
        • 19.1.5.3.1 Deals
        • 19.1.5.3.2 Expansions
      • 19.1.5.4 MnM view
        • 19.1.5.4.1 Key strength
        • 19.1.5.4.2 Strategic choices
        • 19.1.5.4.3 Weaknesses and competitive threats
    • 19.1.6 GENSCRIPT
      • 19.1.6.1 Business overview
      • 19.1.6.2 Products & services offered
      • 19.1.6.3 Recent developments
        • 19.1.6.3.1 Product/Service launches
    • 19.1.7 TAKARA BIO INC.
      • 19.1.7.1 Business overview
      • 19.1.7.2 Products & services offered
      • 19.1.7.3 Recent developments
        • 19.1.7.3.1 Expansions
    • 19.1.8 BIO-RAD LABORATORIES, INC.
      • 19.1.8.1 Business overview
      • 19.1.8.2 Products & services offered
      • 19.1.8.3 Recent developments
        • 19.1.8.3.1 Product launches
        • 19.1.8.3.2 Deals
    • 19.1.9 QIAGEN
      • 19.1.9.1 Business overview
      • 19.1.9.2 Products & services offered
      • 19.1.9.3 Recent developments
        • 19.1.9.3.1 Product launches
        • 19.1.9.3.2 Deals
    • 19.1.10 CHARLES RIVER LABORATORIES
      • 19.1.10.1 Business overview
      • 19.1.10.2 Products & services offered
      • 19.1.10.3 Recent developments
        • 19.1.10.3.1 Product/Service launches
    • 19.1.11 CORNING INCORPORATED
      • 19.1.11.1 Business overview
      • 19.1.11.2 Products & services offered
      • 19.1.11.3 Recent developments
        • 19.1.11.3.1 Product launches
    • 19.1.12 LONZA
      • 19.1.12.1 Business overview
      • 19.1.12.2 Products & services offered
      • 19.1.12.3 Recent developments
        • 19.1.12.3.1 Product launches
        • 19.1.12.3.2 Deals
    • 19.1.13 FUJIFILM HOLDINGS CORPORATION
      • 19.1.13.1 Business overview
      • 19.1.13.2 Products & services offered
      • 19.1.13.3 Recent developments
        • 19.1.13.3.1 Product launches
        • 19.1.13.3.2 Expansions
    • 19.1.14 SYNGENE INTERNATIONAL LIMITED
      • 19.1.14.1 Business overview
      • 19.1.14.2 Products & services offered
      • 19.1.14.3 Recent developments
        • 19.1.14.3.1 Product launches
    • 19.1.15 LGC LIMITED
      • 19.1.15.1 Business overview
      • 19.1.15.2 Products & services offered
    • 19.1.16 EUROFINS SCIENTIFIC
      • 19.1.16.1 Business overview
      • 19.1.16.2 Products & services offered
      • 19.1.16.3 Recent developments
        • 19.1.16.3.1 Expansions
    • 19.1.17 AJINOMOTO CO., INC.
      • 19.1.17.1 Business overview
      • 19.1.17.2 Products & services offered
      • 19.1.17.3 Recent developments
        • 19.1.17.3.1 Deals
  • 19.2 OTHER PLAYERS
    • 19.2.1 PROMEGA CORPORATION
    • 19.2.2 SINO BIOLOGICAL, INC.
    • 19.2.3 RAYBIOTECH, INC.
    • 19.2.4 BIONEER CORPORATION
    • 19.2.5 ORIGENE TECHNOLOGIES, INC.
    • 19.2.6 NEW ENGLAND BIOLABS
    • 19.2.7 ACCURUS BIOSCIENCES
    • 19.2.8 ARAGEN LIFE SCIENCES LTD.
    • 19.2.9 OXFORD EXPRESSION TECHNOLOGIES LTD
    • 19.2.10 PROTEOGENIX INC.
    • 19.2.11 ABEOMICS

20 RESEARCH METHODOLOGY

  • 20.1 RESEARCH DATA
    • 20.1.1 SECONDARY DATA
    • 20.1.2 PRIMARY DATA
  • 20.2 MARKET ESTIMATION METHODOLOGY
    • 20.2.1 MARKET SIZE ESTIMATION
    • 20.2.2 INSIGHTS OF PRIMARY EXPERTS
    • 20.2.3 TOP-DOWN APPROACH
  • 20.3 MARKET GROWTH RATE PROJECTIONS
  • 20.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 20.5 RESEARCH ASSUMPTIONS
  • 20.6 RESEARCH LIMITATIONS
  • 20.7 RISK ANALYSIS

21 APPENDIX

  • 21.1 DISCUSSION GUIDE
  • 21.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 21.3 CUSTOMIZATION OPTIONS
  • 21.4 RELATED REPORTS
  • 21.5 AUTHOR DETAILS
Show more
Product Code: BT 2757

List of Tables

  • TABLE 1 PROTEIN EXPRESSION MARKET: IMPACT ANALYSIS
  • TABLE 2 PROTEIN EXPRESSION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 PROTEIN EXPRESSION MARKET: ROLE IN ECOSYSTEM
  • TABLE 4 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY KEY PLAYER, 2023-2025 (USD)
  • TABLE 5 INDICATIVE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY REGION, 2025 (USD)
  • TABLE 6 IMPORT DATA FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022-2023 (USD THOUSAND)
  • TABLE 7 IMPORT VOLUME FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022-2025, (UNIT/TONS)
  • TABLE 8 EXPORT DATA FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022-2025, (USD THOUSAND)
  • TABLE 9 EXPORT VOLUME FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022-2025, (UNIT/TONS)
  • TABLE 10 PROTEIN EXPRESSION MARKET: KEY CONFERENCES & EVENTS, 2026-2027
  • TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 12 INDICATIVE LIST OF PATENTS IN PROTEIN EXPRESSION MARKET, 2024
  • TABLE 13 CASE STUDIES OF AI IMPLEMENTATION IN PROTEIN EXPRESSION MARKET
  • TABLE 14 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PROTEIN EXPRESSION MARKET
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 COUNTRY-WISE REGULATORY SCENARIO FOR PROTEIN EXPRESSION PRODUCT & SERVICE PROVIDERS
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
  • TABLE 21 KEY BUYING CRITERIA, BY END USER
  • TABLE 22 PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 23 PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 24 PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 25 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 26 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 28 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 29 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 30 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 31 PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 32 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 33 NORTH AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 34 EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 37 MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 38 GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 CULTURE MEDIA & SUPPLEMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 40 NORTH AMERICA: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 EUROPE: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 LATIN AMERICA: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 MIDDLE EAST: CULTURE MEDIA & SUPPLEMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 45 GCC COUNTRIES: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 EXPRESSION VECTORS & PLASMIDS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 47 NORTH AMERICA: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 EUROPE: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 LATIN AMERICA: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 MIDDLE EAST: EXPRESSION VECTORS & PLASMIDS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 52 GCC COUNTRIES: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 54 NORTH AMERICA: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 EUROPE: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 LATIN AMERICA: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 MIDDLE EAST: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 59 GCC COUNTRIES: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 COMPETENT CELLS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 61 NORTH AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 EUROPE: COMPETENT CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: COMPETENT CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 64 LATIN AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 MIDDLE EAST: COMPETENT CELLS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 66 GCC COUNTRIES: COMPETENT CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 68 NORTH AMERICA: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 EUROPE: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 71 LATIN AMERICA: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 72 MIDDLE EAST: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 74 PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 75 PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 76 NORTH AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 79 LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 81 GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 82 PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 83 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 84 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 86 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 87 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 88 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 89 CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 90 NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 91 EUROPE: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 93 LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 94 MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 95 GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 96 ANALYTICAL INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 97 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 98 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 100 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 101 MIDDLE EAST: ANALYTICAL INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 102 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 103 LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 104 NORTH AMERICA: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 105 EUROPE: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 LATIN AMERICA: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 108 MIDDLE EAST: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 109 GCC COUNTRIES: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 110 FILTRATION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 111 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 112 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 114 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 115 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 116 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 117 OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 118 NORTH AMERICA: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 119 EUROPE: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 121 LATIN AMERICA: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 122 MIDDLE EAST: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 123 GCC COUNTRIES: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 124 PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 125 PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 126 NORTH AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 127 EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 129 LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 130 MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 131 GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 132 CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 133 NORTH AMERICA: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 134 EUROPE: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 136 LATIN AMERICA: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 137 MIDDLE EAST: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 138 GCC COUNTRIES: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 139 FILTRATION & SEPARATION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 140 NORTH AMERICA: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 141 EUROPE: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 143 LATIN AMERICA: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 144 MIDDLE EAST: FILTRATION & SEPARATION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 145 GCC COUNTRIES: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 146 OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 147 NORTH AMERICA: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 148 EUROPE: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 150 LATIN AMERICA: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 151 MIDDLE EAST: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 152 GCC COUNTRIES: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 153 PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 154 PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 155 NORTH AMERICA: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 156 EUROPE: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 158 LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 159 MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 160 GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 161 EXPRESSION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 162 NORTH AMERICA: EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 163 EUROPE: EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 165 LATIN AMERICA: EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 166 MIDDLE EAST: EXPRESSION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 167 GCC COUNTRIES: EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 168 CLONING & MUTAGENESIS KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 169 NORTH AMERICA: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 170 EUROPE: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 172 LATIN AMERICA: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 173 MIDDLE EAST: CLONING & MUTAGENESIS KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 174 GCC COUNTRIES: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 175 OTHER PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 176 NORTH AMERICA: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 177 EUROPE: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 179 LATIN AMERICA: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 180 MIDDLE EAST: OTHER PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 181 GCC COUNTRIES: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 182 PROTEIN EXPRESSION SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 183 NORTH AMERICA: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 184 EUROPE: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 186 LATIN AMERICA: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 187 MIDDLE EAST: PROTEIN EXPRESSION SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 188 GCC COUNTRIES: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 189 PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 190 PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 191 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 192 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 193 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 194 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 195 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 196 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 197 CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 198 NORTH AMERICA: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 199 EUROPE: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 200 ASIA PACIFIC: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 201 LATIN AMERICA: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 202 MIDDLE EAST: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 203 GCC COUNTRIES: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 204 GENE SYNTHESIS & CLONING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 205 NORTH AMERICA: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 206 EUROPE: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 207 ASIA PACIFIC: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 208 LATIN AMERICA: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 209 MIDDLE EAST: GENE SYNTHESIS & CLONING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 210 GCC COUNTRIES: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 211 CELL LINE DEVELOPMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 212 NORTH AMERICA: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 213 EUROPE: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 215 LATIN AMERICA: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 216 MIDDLE EAST: CELL LINE DEVELOPMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 217 GCC COUNTRIES: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 218 PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 219 NORTH AMERICA: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 220 EUROPE: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 222 LATIN AMERICA: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 223 MIDDLE EAST: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 225 PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 226 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 228 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 229 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 230 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 231 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 232 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 233 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 234 PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 235 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 236 EUROPE: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 238 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 239 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 240 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 241 PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 242 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 243 EUROPE: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 245 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 246 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 247 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 248 PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 249 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 250 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 251 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 252 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 253 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 254 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 255 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 256 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 257 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 258 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 260 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 261 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 263 PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 264 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 265 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 266 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 267 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 268 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 269 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 270 PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 271 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 272 EUROPE: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 273 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 274 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 275 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 276 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 277 PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 278 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 279 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 280 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 281 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 282 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 284 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 286 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 287 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 288 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 289 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 290 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 291 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 292 PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 293 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 294 EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 296 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 297 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 298 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 299 PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 300 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 301 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 302 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 303 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 304 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 305 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 306 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 307 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 308 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 309 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 311 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 312 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 313 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 314 PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 315 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 316 EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 318 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 319 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 320 GCC COUNTRIES: PROTEIN EXPRESSION MARKET PICHIA SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 321 PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 322 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 323 EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 325 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 326 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 327 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 328 PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 329 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 330 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 332 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 333 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION REGION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 334 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 335 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 336 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 337 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 338 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 340 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 341 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 342 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 343 PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 344 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 345 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 347 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 348 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: PROTEIN EXPRESSION MARKET E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 350 PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 351 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 352 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 354 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 355 MIDDLE EAST: PROTEIN EXPRESSION MARKET OTHER CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 356 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 357 PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 358 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 359 EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 360 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 361 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 362 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 363 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 364 PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 365 PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 366 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 367 EUROPE: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 368 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 369 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 370 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 371 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 372 PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 373 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 374 EUROPE: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 375 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 376 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 377 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 378 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 379 PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 380 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 381 EUROPE: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 382 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 383 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 384 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 385 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 386 PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 387 PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 388 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 389 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 390 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 391 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 392 MIDDLE EAST: PROTEIN PRODUCTS EXPRESSION MARKET FOR DISCOVERY & RESEARCH SCALE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 393 GCC COUNTRIES: PROTEIN PRODUCTS EXPRESSION MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 394 PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 395 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 396 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 397 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 398 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 399 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 400 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 401 PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 402 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 403 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 404 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 405 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 406 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 407 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 408 PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 409 PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 410 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 411 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 412 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 413 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 414 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 415 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 416 PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 417 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 418 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 419 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 420 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 421 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 423 PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 424 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 425 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 426 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 427 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 428 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 429 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 430 PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 431 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 432 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 433 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 434 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 435 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 436 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 437 PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 438 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 439 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 440 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 441 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 442 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 443 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 444 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 445 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 446 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 447 EUROPE: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 448 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 449 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 450 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 451 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 452 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 453 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 454 EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 455 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 456 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 457 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 458 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 459 LIST OF INDUSTRIAL ENZYMES AND APPLICATIONS
  • TABLE 460 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 461 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 462 EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 463 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 464 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 465 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 466 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 467 PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 468 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 469 EUROPE: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 470 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 471 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 472 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 473 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 474 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 475 PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 476 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 477 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 478 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 479 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 480 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 481 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 482 PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 483 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 484 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 485 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 486 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 487 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 488 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 489 PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 490 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 491 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 492 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 493 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 494 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 495 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 496 PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 497 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 498 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 499 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 500 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 501 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 502 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 503 PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 504 PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 505 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 506 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 507 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 508 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 509 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 510 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 511 PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 512 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 513 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 514 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 515 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 516 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 517 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 518 PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 519 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 520 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 521 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 522 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 523 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 524 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 525 PROTEIN EXPRESSION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 526 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 527 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 528 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 529 NORTH AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 530 NORTH AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 531 NORTH AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 532 NORTH AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 533 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 534 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 535 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 536 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 537 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 538 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 539 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 540 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 541 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 542 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 543 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 544 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 545 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 546 US: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 547 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 548 US: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 549 US: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 550 US: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 551 US: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 552 US: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 553 US: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 554 US: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 555 US: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 556 US: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 557 US: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 558 US: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 559 US: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 560 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 561 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 562 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 563 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 564 US: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 565 CANADA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 566 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 567 CANADA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 568 CANADA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 569 CANADA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 570 CANADA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 571 CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 572 CANADA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 573 CANADA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 574 CANADA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 575 CANADA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 576 CANADA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 577 CANADA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 578 CANADA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 579 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 580 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 581 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 582 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 583 CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 584 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 585 EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 586 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 587 EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 588 EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 589 EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 590 EUROPE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 591 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 592 EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 593 EUROPE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 594 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 595 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 596 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 597 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 598 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 599 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 600 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 601 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 602 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 603 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 604 GERMANY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 605 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 606 GERMANY: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 607 GERMANY: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 608 GERMANY: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 609 GERMANY: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 610 GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 611 GERMANY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 612 GERMANY: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 613 GERMANY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 614 GERMANY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 615 GERMANY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 616 GERMANY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 617 GERMANY: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 618 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 619 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 620 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 621 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 622 GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 623 UK: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 624 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 625 UK: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 626 UK: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 627 UK: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 628 UK: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 629 UK: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 630 UK: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 631 UK: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 632 UK: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 633 UK: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 634 UK: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 635 UK: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 636 UK: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 637 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 638 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 639 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 640 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 641 UK: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 642 FRANCE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 643 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 644 FRANCE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 645 FRANCE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 646 FRANCE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 647 FRANCE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 648 FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 649 FRANCE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 650 FRANCE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 651 FRANCE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 652 FRANCE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 653 FRANCE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 654 FRANCE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 655 FRANCE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 656 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 657 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 658 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 659 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 660 FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 661 ITALY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 662 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 663 ITALY: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 664 ITALY: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 665 ITALY: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 666 ITALY: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 667 ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 668 ITALY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 669 ITALY: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 670 ITALY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 671 ITALY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 672 ITALY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 673 ITALY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 674 ITALY: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 675 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 676 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 677 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 678 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 679 ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 680 SPAIN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 681 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 682 SPAIN: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 683 SPAIN: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 684 SPAIN: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 685 SPAIN: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 686 SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 687 SPAIN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 688 SPAIN: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 689 SPAIN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 690 SPAIN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 691 SPAIN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 692 SPAIN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 693 SPAIN: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 694 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 695 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 696 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 697 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 698 SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 699 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 700 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 701 NETHERLANDS: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 702 NETHERLANDS: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 703 NETHERLANDS: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 704 NETHERLANDS: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 705 NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 706 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 707 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 708 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 709 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 710 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 711 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 712 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 713 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 714 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 715 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 716 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 717 NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 718 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 719 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 720 REST OF EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 721 REST OF EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 722 REST OF EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 723 REST OF EUROPE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 724 REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 725 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 726 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 727 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 728 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 729 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 730 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 731 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 732 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 733 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 734 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 735 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 736 REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 737 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 738 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 739 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 740 ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 741 ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 742 ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 743 ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 744 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 745 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 746 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 747 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 748 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 749 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 750 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 751 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 752 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 753 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 754 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 755 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 756 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 757 CHINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 758 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 759 CHINA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 760 CHINA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 761 CHINA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 762 CHINA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 763 CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 764 CHINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 765 CHINA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 766 CHINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 767 CHINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 768 CHINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 769 CHINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 770 CHINA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 771 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 772 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 773 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 774 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 775 CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 776 JAPAN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 777 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 778 JAPAN: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 779 JAPAN: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 780 JAPAN: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 781 JAPAN: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 782 JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 783 JAPAN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 784 JAPAN: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 785 JAPAN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 786 JAPAN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 787 JAPAN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 788 JAPAN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 789 JAPAN: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 790 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 791 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 792 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 793 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 794 JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 795 INDIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 796 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 797 INDIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 798 INDIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 799 INDIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 800 INDIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 801 INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 802 INDIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 803 INDIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 804 INDIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 805 INDIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 806 INDIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 807 INDIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 808 INDIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 809 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 810 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 811 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 812 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 813 INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 814 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 815 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 816 AUSTRALIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 817 AUSTRALIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 818 AUSTRALIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 819 AUSTRALIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 820 AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 821 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 822 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 823 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 824 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 825 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 826 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 827 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 828 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 829 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 830 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 831 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 832 AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 833 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 834 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 835 SOUTH KOREA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 836 SOUTH KOREA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 837 SOUTH KOREA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 838 SOUTH KOREA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 839 SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 840 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 841 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 842 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 843 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 844 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 845 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 846 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 847 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 848 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 849 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 850 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 851 SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 852 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 853 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 854 REST OF ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 855 REST OF ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 856 REST OF ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 857 REST OF ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 858 REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 859 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 860 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 861 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 862 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 863 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 864 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 865 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 866 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 867 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 868 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 869 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 870 REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 871 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 872 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 873 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 874 LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 875 LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 876 LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 877 LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 878 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 879 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 880 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 881 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 882 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 883 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 884 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 885 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 886 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 887 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 888 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 889 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 890 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 891 BRAZIL: BRAZIL: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 892 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 893 BRAZIL: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 894 BRAZIL: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 895 BRAZIL: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 896 BRAZIL: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 897 BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 898 BRAZIL: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 899 BRAZIL: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 900 BRAZIL: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 901 BRAZIL: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 902 BRAZIL: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 903 BRAZIL: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 904 BRAZIL: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 905 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 906 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 907 BRAZIL: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 908 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 909 BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 910 MEXICO: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 911 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 912 MEXICO: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 913 MEXICO: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 914 MEXICO: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 915 MEXICO: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 916 MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 917 MEXICO: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 918 MEXICO: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 919 MEXICO: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 920 MEXICO: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 921 MEXICO: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 922 MEXICO: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 923 MEXICO: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 924 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 925 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 926 MEXICO: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 927 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 928 MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 929 ARGENTINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 930 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 931 ARGENTINA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 932 ARGENTINA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 933 ARGENTINA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 934 ARGENTINA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 935 ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 936 ARGENTINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 937 ARGENTINA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 938 ARGENTINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 939 ARGENTINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 940 ARGENTINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 941 ARGENTINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 942 ARGENTINA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 943 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 944 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 945 ARGENTINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 946 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 947 ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 948 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 949 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 950 REST OF LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 951 REST OF LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 952 REST OF LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 953 REST OF LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 954 REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 955 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 956 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 957 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 958 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 959 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 960 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 961 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 962 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 963 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 964 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 965 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 966 REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 967 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 968 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 969 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 970 MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 971 MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 972 MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 973 MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 974 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 975 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 976 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 977 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 978 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 979 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 980 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 981 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 982 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 983 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 984 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 985 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 986 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 987 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 988 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 989 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 990 GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 991 GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 992 GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 993 GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 994 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 995 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 996 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 997 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 998 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 999 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1000 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1001 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1002 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 1003 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 1004 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 1005 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1006 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1007 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 1008 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1009 SAUDI ARABIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1010 SAUDI ARABIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1011 SAUDI ARABIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1012 SAUDI ARABIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1013 SAUDI ARABIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1014 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 1015 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1016 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1017 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1018 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1019 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1020 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1021 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 1022 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 1023 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 1024 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1025 SAUDI ARABIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1026 UAE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 1027 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1028 UAE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1029 UAE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1030 UAE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1031 UAE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1032 UAE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1033 UAE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 1034 UAE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1035 UAE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1036 UAE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1037 UAE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1038 UAE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1039 UAE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1040 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 1041 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 1042 UAE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 1043 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1044 UAE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1045 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 1046 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1047 REST OF GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1048 REST OF GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1049 REST OF GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1050 REST OF GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1051 REST OF GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1052 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 1053 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1054 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1055 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1056 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1057 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1058 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1059 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 1060 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 1061 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 1062 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1063 REST OF GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1064 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 1065 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1066 REST OF MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1067 REST OF MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1068 REST OF MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1069 REST OF MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1070 REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1071 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 1072 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1073 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1074 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1075 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1076 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1077 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1078 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 1079 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 1080 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 1081 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1082 REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1083 AFRICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 1084 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1085 AFRICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1086 AFRICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1087 AFRICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1088 AFRICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1089 AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1090 AFRICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
  • TABLE 1091 AFRICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1092 AFRICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1093 AFRICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1094 AFRICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1095 AFRICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1096 AFRICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 1097 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024-2031 (USD MILLION)
  • TABLE 1098 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024-2031 (USD MILLION)
  • TABLE 1099 AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 1100 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1101 AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 1102 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET
  • TABLE 1103 PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION
  • TABLE 1104 PROTEIN EXPRESSION MARKET: REGION FOOTPRINT
  • TABLE 1105 PROTEIN EXPRESSION MARKET: OFFERING FOOTPRINT
  • TABLE 1106 PROTEIN EXPRESSION MARKET: TYPE FOOTPRINT
  • TABLE 1107 PROTEIN EXPRESSION MARKET: APPLICATION FOOTPRINT
  • TABLE 1108 PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 1109 PROTEIN EXPRESSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 1110 PROTEIN EXPRESSION MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1111 PROTEIN EXPRESSION MARKET: DEALS, JANUARY 2023-MAY 2026
  • TABLE 1112 PROTEIN EXPRESSION MARKET: EXPANSIONS, JANUARY 2023-MAY 2026
  • TABLE 1113 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 1114 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 1115 THERMO FISHER SCIENTIFIC INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1116 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2023-MAY 2026
  • TABLE 1117 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-MAY 2026
  • TABLE 1118 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 1119 MERCK KGAA: PRODUCTS & SERVICES OFFERED
  • TABLE 1120 MERCK KGAA: DEALS, JANUARY 2023-MAY 2026
  • TABLE 1121 MERCK KGAA: EXPANSIONS, JANUARY 2023-MAY 2026
  • TABLE 1122 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 1123 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 1124 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1125 DANAHER CORPORATION: DEALS, JANUARY 2023-MAY 2026
  • TABLE 1126 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023-MAY 2026
  • TABLE 1127 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 1128 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 1129 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1130 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023-MAY 2026
  • TABLE 1131 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 1132 SARTORIUS AG: PRODUCTS & SERVICES OFFERED
  • TABLE 1133 SARTORIUS AG: DEALS, JANUARY 2023-MAY 2026
  • TABLE 1134 SARTORIUS AG: EXPANSIONS, JANUARY 2023-MAY 2026
  • TABLE 1135 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 1136 GENSCRIPT: PRODUCTS & SERVICES OFFERED
  • TABLE 1137 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1138 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 1139 TAKARA BIO INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 1140 TAKARA BIO INC.: EXPANSIONS, JANUARY 2023-MAY 2026
  • TABLE 1141 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 1142 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 1143 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1144 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023-MAY 2026
  • TABLE 1145 QIAGEN: COMPANY OVERVIEW
  • TABLE 1146 QIAGEN: PRODUCTS & SERVICES OFFERED
  • TABLE 1147 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023- APRIL 2026
  • TABLE 1148 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023- APRIL 2026
  • TABLE 1149 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 1150 CHARLES RIVER LABORATORIES: PRODUCTS & SERVICES OFFERED
  • TABLE 1151 CHARLES RIVER LABORATORIES: PRODUCT/SERVICE LAUNCHES, JANUARY 2023- APRIL 2026
  • TABLE 1152 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 1153 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED
  • TABLE 1154 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2023- APRIL 2026
  • TABLE 1155 LONZA: COMPANY OVERVIEW
  • TABLE 1156 LONZA: PRODUCTS & SERVICES OFFERED
  • TABLE 1157 LONZA: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1158 LONZA: DEALS, JANUARY 2023-MAY 2026
  • TABLE 1159 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 1160 FUJIFILM CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 1161 FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1162 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2023-MAY 2026
  • TABLE 1163 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW
  • TABLE 1164 SYNGENE INTERNATIONAL LIMITED: PRODUCTS & SERVICES OFFERED
  • TABLE 1165 SYNGENE INTERNATIONAL LIMITED: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
  • TABLE 1166 LGC LIMITED: COMPANY OVERVIEW
  • TABLE 1167 LGC LIMITED: PRODUCTS & SERVICES OFFERED
  • TABLE 1168 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 1169 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
  • TABLE 1170 EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023- APRIL 2026
  • TABLE 1171 AJINOMOTO CO., INC.: COMPANY OVERVIEW
  • TABLE 1172 AJINOMOTO CO., INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 1173 AJINOMOTO CO., INC.: DEALS, JANUARY 2023- APRIL 2026
  • TABLE 1174 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 1175 SINO BIOLOGICAL, INC.: COMPANY OVERVIEW
  • TABLE 1176 RAYBIOTECH, INC.: COMPANY OVERVIEW
  • TABLE 1177 BIONEER CORPORATION: COMPANY OVERVIEW
  • TABLE 1178 ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 1179 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 1180 ACCURUS BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 1181 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
  • TABLE 1182 OXFORD EXPRESSION TECHNOLOGIES LTD: COMPANY OVERVIEW
  • TABLE 1183 PROTEOGENIX INC.: COMPANY OVERVIEW
  • TABLE 1184 ABEOMICS: COMPANY OVERVIEW
  • TABLE 1185 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS

List of Figures

  • FIGURE 1 MARKET SCENARIO
  • FIGURE 2 GLOBAL PROTEIN EXPRESSION MARKET, 2024-2031
  • FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET, 2023-2026
  • FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PROTEIN EXPRESSION MARKET
  • FIGURE 5 HIGH-GROWTH SEGMENTS IN PROTEIN EXPRESSION MARKET, 2026-2031
  • FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN THE PROTEIN EXPRESSION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 7 CONTINUOUS INNOVATION IN EXPRESSION TECHNOLOGIES TO DRIVE GROWTH IN PROTEIN EXPRESSION MARKET
  • FIGURE 8 PRODUCT SEGMENT IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
  • FIGURE 9 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 10 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 11 PROTEIN EXPRESSION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12 PROTEIN EXPRESSION PRODUCTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 13 PROTEIN EXPRESSION SERVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 14 PROTEIN EXPRESSION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 15 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY KEY PLAYER
  • FIGURE 16 INDICATIVE SELLING PRICE TREND OF PROTEIN EXPRESSION SYSTEMS, BY REGION, 2025 (USD)
  • FIGURE 17 PROTEIN EXPRESSION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 18 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
  • FIGURE 19 TOP APPLICANTS/OWNERS (COMPANIES) FOR PROTEIN EXPRESSION PATENTS, 2015-2025
  • FIGURE 20 IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET
  • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 22 KEY BUYING CRITERIA, BY END USER
  • FIGURE 23 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 24 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS, 2023-2025 (USD MILLION)
  • FIGURE 26 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
  • FIGURE 27 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 28 PROTEIN EXPRESSION MARKET: COMPANY FOOTPRINT
  • FIGURE 29 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 31 EV/EBITDA OF KEY VENDORS
  • FIGURE 32 PROTEIN EXPRESSION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 33 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2025)
  • FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2025)
  • FIGURE 38 GENSCRIPT: COMPANY SNAPSHOT (2025)
  • FIGURE 39 TAKARA BIO INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 40 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 41 QIAGEN: COMPANY SNAPSHOT (2025)
  • FIGURE 42 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025)
  • FIGURE 43 CORNING INCORPORATED: COMPANY SNAPSHOT (2025)
  • FIGURE 44 LONZA: COMPANY SNAPSHOT (2025)
  • FIGURE 45 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 46 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2025)
  • FIGURE 47 LGC LIMITED: COMPANY SNAPSHOT (2025)
  • FIGURE 48 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
  • FIGURE 49 AJINOMOTO CO., INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 50 RESEARCH DESIGN
  • FIGURE 51 PROTEIN EXPRESSION MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 52 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
  • FIGURE 53 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025
  • FIGURE 54 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC. (2025)
  • FIGURE 55 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 56 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 57 PROTEIN EXPRESSION MARKET CAGR PROJECTIONS:
  • FIGURE 58 DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!